TCR2 Therapeutics Inc. a clinical-stage immunotherapy company developing the next generation of novel T cell therapies for patients suffering from cancer, today announced the appointment of Angela Justice, Ph.D., as its first Chief People Officer. In her new role, Dr. Justice will be responsible for leading all aspects of TCR2’s human resources function including the development and execution of Human Capital strategy.  

“We are delighted to announce the appointment of Angela to the TCR2 executive team,” said Garry Menzel, Ph.D., President and Chief Executive Officer of TCR2 Therapeutics. “She will enhance our commitment to a performance-driven culture of innovation and further develop our outstanding employee base. Over the course of her career, Angela has consistently focused on improving the employee experience by providing clarity of purpose, measurable metrics and resources for continuous learning. Her unique background in business, academia and medical affairs will prove invaluable as we embark on the next phase of our growth and transformation as a company dedicated to the common goal of curing cancer with our TRuC-T cell therapies.”

Dr. Justice brings to TCR2 nearly 20 years of experience in healthcare, medical affairs and human resources leadership. Prior to joining the Company, she was Executive Vice President and Chief Human Resources Officer at Surgery Partners, Inc., where she played a critical role in advancing the company’s objectives by leading succession planning, talent management strategy and launching a multi-year rewards strategy to incentivize organic growth. 

Before that, Dr. Justice worked at Biogen, Inc. as the Chief Learning Officer where she assumed a variety of responsibilities including creating and leading a centralized learning organization supporting 14,000 people across all departments and geographies, spearheading the implementation of a learning technology system that was considered one of Biogen’s largest and most successful IT projects, and making learning a competitive force with measurable business impact. 

Earlier at Biogen, Angela served as Senior Director of Global Medical Affairs, where she supported 5 international product launches and led the organization to create scalable processes and capabilities focused on advancing scientific excellence globally. Additionally, she was an active member of the Human Resources Leadership Team. 

"I am thrilled to be joining at such an exciting time in the Company’s development and growth," said Dr. Justice. "What attracted me to TCR2 was observing how culture and community play critical roles in the Company’s vision for building a talented and motivated organization. These are hallmarks for successful growth, and I look forward to reinforcing these values and scaling the Company’s legacy as we further develop our manufacturing facility in the United Kingdom.”

Previously, she held leadership roles at EMD Serono, the National MS Society and was a management consultant at McKinsey & Company. Dr. Justice received her Ph.D. in Biopsychology from the University of Chicago, where she was also an adjunct faculty member.